- Report
- February 2024
- 110 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- December 2020
- 280 Pages
Global
From €3074EUR$3,185USD£2,637GBP
€4392EUR$4,550USD£3,767GBP
- Report
- January 2022
- 60 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Report
- January 2019
- 30 Pages
China
From €2123EUR$2,200USD£1,821GBP
- Report
- December 2022
- 217 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- December 2022
- 79 Pages
North America
From €1448EUR$1,500USD£1,242GBP
Gonal is a brand of sexual and reproductive health drugs used to treat infertility in women. It is a recombinant follicle-stimulating hormone (rFSH) that helps to stimulate the growth of ovarian follicles, which are necessary for ovulation. Gonal is used in combination with other fertility drugs to increase the chances of conception. It is also used to treat certain types of ovarian cysts and to induce ovulation in women with polycystic ovary syndrome.
Gonal is available in both injectable and subcutaneous forms, and is typically administered by a healthcare professional. It is a prescription drug and is available in many countries around the world.
The Gonal market is highly competitive, with a number of companies offering similar products. Some of the major players in the market include Merck, Ferring Pharmaceuticals, EMD Serono, Teva Pharmaceuticals, and Merck KGaA. Show Less Read more
